327 related articles for article (PubMed ID: 20600980)
1. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
Tziortzi AC; Searle GE; Tzimopoulou S; Salinas C; Beaver JD; Jenkinson M; Laruelle M; Rabiner EA; Gunn RN
Neuroimage; 2011 Jan; 54(1):264-77. PubMed ID: 20600980
[TBL] [Abstract][Full Text] [Related]
2. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
[TBL] [Abstract][Full Text] [Related]
3. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
[TBL] [Abstract][Full Text] [Related]
4. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
[TBL] [Abstract][Full Text] [Related]
5. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
[TBL] [Abstract][Full Text] [Related]
6. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
7. High-affinity states of human brain dopamine D2/3 receptors imaged by the agonist [11C]-(+)-PHNO.
Willeit M; Ginovart N; Kapur S; Houle S; Hussey D; Seeman P; Wilson AA
Biol Psychiatry; 2006 Mar; 59(5):389-94. PubMed ID: 16373068
[TBL] [Abstract][Full Text] [Related]
8. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
9. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.
Matuskey D; Worhunksy P; Correa E; Pittman B; Gallezot JD; Nabulsi N; Ropchan J; Sreeram V; Gudepu R; Gaiser E; Cosgrove K; Ding YS; Potenza MN; Huang Y; Malison RT; Carson RE
Neuroimage; 2016 Apr; 130():241-247. PubMed ID: 26876475
[TBL] [Abstract][Full Text] [Related]
11. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.
Suridjan I; Rusjan P; Addington J; Wilson AA; Houle S; Mizrahi R
J Psychiatry Neurosci; 2013 Mar; 38(2):98-106. PubMed ID: 23010256
[TBL] [Abstract][Full Text] [Related]
13. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ
J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219
[TBL] [Abstract][Full Text] [Related]
14. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
[TBL] [Abstract][Full Text] [Related]
15. The relationship between subcortical brain volume and striatal dopamine D
Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
[TBL] [Abstract][Full Text] [Related]
16. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
[TBL] [Abstract][Full Text] [Related]
18. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
[TBL] [Abstract][Full Text] [Related]
19. Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.
Egerton A; Hirani E; Ahmad R; Turton DR; Brickute D; Rosso L; Howes OD; Luthra SK; Grasby PM
Synapse; 2010 Apr; 64(4):301-12. PubMed ID: 19957364
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]